Shopping Cart 0
Cart Subtotal
AED 0

Blood Products Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option : NO
Copy Option : No
Download Option: No
Deliverable Format : Excel viewable on the website via username

Excel Only
AED 11010

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 27525

Details

Market Overview

Any component or portion of blood that is harvested from a donor for use in patients is referred to as a blood product. Not every patient requires complete blood transfusion; many simply require transfusion of certain blood components. Several blood components are isolated from the total blood in such circumstances. Platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products are among the blood products available. An individual is given a specific blood product depending on their condition. Blood is an extremely important bodily fluid that ensures the proper functioning of organs. However, there are a variety of chronic medical problems that cause the body's red blood cell count to drop. Diseases like leukemia, cancer, and end-stage renal disease, for example, cause significant consequences that necessitate blood transfusions.

Blood Products Market: Key Players

  • Abbott Laboratories

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • American Red Cross
  • America`s Blood Centers
  • BPL Inc.
  • CSL
  • Mitsubishi Tanabe Pharma Corporation
  • Bharat Serums and Vaccines Ltd.
  • Bio Products Laboratory Ltd.
  • Kedrion S.p.A
  • Bio-Rad Laboratories, Inc.
  • Octapharma AG
  • Canadian Blood Services

 

Growth Factor

Rise in geriatric population

According to the World Health Organization, the worldwide population of people aged 60 and over will nearly double from 12 percent to 22 percent between 2015 and 2050, with 80 percent of the aging population residing in low- and middle-income nations. The world's ageing population may result in a rise in illnesses that require plasma treatment. As a result, the market will develop faster as the senior population grows.

Segmentation

  • By Product Type
    • Platelets
    • Fresh Frozen Plasma (FFP)
    • Red Blood Cells (RBCs)
    • White Blood Cells (WBCs)
    • Others
  • By End-User
    • Hospitals
    • Blood Station
    • Others
  • Blood Products Market Dynamics
  • Blood Products Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

 

Recent News Related to Market

  1. North America is the market leader for blood plasma products, accounting for 44.2 percent of the market in 2018. This is owing to the increased prevalence of hemophilia and the FDA's quick approval of plasma products.
  2. In October 2018, The FDA revised its criteria on dried plasma products for blood transfusion, including everything from the best sources of input plasma to device submissions.

 

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

  • COVID-19 pre and post business impact analysis
  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • What is the Blood Products Market growth?
  • Which segment accounted for the largest Blood Products Market share?
  • Who are the key players in the Blood Products Market?
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

 

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

READ MORE

Table Of Content

Scope

Contents          

  1. Executive Summary
  2. Global Blood Products Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Blood Products Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Blood Products Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Blood Products Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Product: Market Share (2020-2030F)
      1. Platelets, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Fresh Frozen Plasma (FFP), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Red Blood Cells (RBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. White Blood Cells (WBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By End-User: Market Share (2020-2030F)
      1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Blood Station, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. American Red Cross
  3. America`s Blood Centers
  4. BPL Inc.
  5. CSL
  6. Mitsubishi Tanabe Pharma Corporation
  7. Bharat Serums and Vaccines Ltd.
  8. Bio Products Laboratory Ltd.
  9. Kedrion S.p.A
  10. Bio-Rad Laboratories, Inc.
  11. Octapharma AG
  12. Canadian Blood Services

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Licence Rights

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Market Overview

Any component or portion of blood that is harvested from a donor for use in patients is referred to as a blood product. Not every patient requires complete blood transfusion; many simply require transfusion of certain blood components. Several blood components are isolated from the total blood in such circumstances. Platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products are among the blood products available. An individual is given a specific blood product depending on their condition. Blood is an extremely important bodily fluid that ensures the proper functioning of organs. However, there are a variety of chronic medical problems that cause the body's red blood cell count to drop. Diseases like leukemia, cancer, and end-stage renal disease, for example, cause significant consequences that necessitate blood transfusions.

Blood Products Market: Key Players

  • Abbott Laboratories

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • American Red Cross
  • America`s Blood Centers
  • BPL Inc.
  • CSL
  • Mitsubishi Tanabe Pharma Corporation
  • Bharat Serums and Vaccines Ltd.
  • Bio Products Laboratory Ltd.
  • Kedrion S.p.A
  • Bio-Rad Laboratories, Inc.
  • Octapharma AG
  • Canadian Blood Services

 

Growth Factor

Rise in geriatric population

According to the World Health Organization, the worldwide population of people aged 60 and over will nearly double from 12 percent to 22 percent between 2015 and 2050, with 80 percent of the aging population residing in low- and middle-income nations. The world's ageing population may result in a rise in illnesses that require plasma treatment. As a result, the market will develop faster as the senior population grows.

Segmentation

  • By Product Type
    • Platelets
    • Fresh Frozen Plasma (FFP)
    • Red Blood Cells (RBCs)
    • White Blood Cells (WBCs)
    • Others
  • By End-User
    • Hospitals
    • Blood Station
    • Others
  • Blood Products Market Dynamics
  • Blood Products Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

 

Recent News Related to Market

  1. North America is the market leader for blood plasma products, accounting for 44.2 percent of the market in 2018. This is owing to the increased prevalence of hemophilia and the FDA's quick approval of plasma products.
  2. In October 2018, The FDA revised its criteria on dried plasma products for blood transfusion, including everything from the best sources of input plasma to device submissions.

 

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

  • COVID-19 pre and post business impact analysis
  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • What is the Blood Products Market growth?
  • Which segment accounted for the largest Blood Products Market share?
  • Who are the key players in the Blood Products Market?
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

 

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

READ MORE

Scope

Contents          

  1. Executive Summary
  2. Global Blood Products Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Blood Products Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Blood Products Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Blood Products Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Product: Market Share (2020-2030F)
      1. Platelets, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Fresh Frozen Plasma (FFP), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Red Blood Cells (RBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. White Blood Cells (WBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By End-User: Market Share (2020-2030F)
      1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Blood Station, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. American Red Cross
  3. America`s Blood Centers
  4. BPL Inc.
  5. CSL
  6. Mitsubishi Tanabe Pharma Corporation
  7. Bharat Serums and Vaccines Ltd.
  8. Bio Products Laboratory Ltd.
  9. Kedrion S.p.A
  10. Bio-Rad Laboratories, Inc.
  11. Octapharma AG
  12. Canadian Blood Services

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

  • Single User License:

    Access to the soft copy of the report will be granted to individual user/ Authorized User within the organization. The Authorized User may store, display or archive the information but will not be able to print, copy and use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete/part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. The report will be MAC address protected and will only be accessible on 1 platform.

  •  
  • Hard Copy License:

    The license provides the access to hard copy/ printed copy of the report to the Authorized User only. The report will be delivered to the user on the address provided during making the purchase. The Authorized User may store, display, or archive the information but will not use any information in the report for circulation or citation purpose. The individual user will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view. No soft copy access will be provided in this case.

  •  
  • Corporate User License:

    Access to the soft copy of the report will be granted to multiple users within the organization. The users are authorized to store, display, duplicate, archive, print and distribute the information within the organization either electronically or in paper. The users are not authorized to use any information in the report for citation and circulation externally. The users will treat the information in the report as confidential and will only use this for internal purpose. In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS